{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:29:38Z","timestamp":1771658978975,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disease that is characterized by its clinical heterogeneity and complex pathophysiology. This complexity comes from the diversity of pathophysiological factors that have been proposed to be involved in the natural history of the disorder. Many theories on OCD pathology support inflammation as a pathophysiological factor, although studies are not consistent on the presence of a pro-inflammatory state among OCD patients. However, some pre-clinical animal studies suggest lipocalin-2 (LCN2), an analogous form of the acute-phase pro-inflammatory protein neutrophil gelatinase-associated lipocalin (NGAL), may be involved in in the regulation of the stress response, which is thought to be disrupted in OCD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-one OCD patients and 19 healthy subjects participated in this exploratory study. Levels of NGAL were assessed in the peripherous blood of all participants. Severity of disease was assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>OCD patients exhibited significantly higher levels of NGAL when compared to healthy control subjects. No correlation was found between elevated levels of NGAL and severity of symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study to report elevated levels of NGAL among OCD patients, adding evidence for a possible role of immune dysregulation in the pathophysiology of OCD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-021-03289-w","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T04:02:33Z","timestamp":1622001753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated levels of neutrophil gelatinase-associated lipocalin among OCD patients: an exploratory study"],"prefix":"10.1186","volume":"21","author":[{"given":"Catarina","family":"Raposo-Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas Miguel","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"3289_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5). Arlington, VA: American Psychiatric Association; 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"3289_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/9781108164313.006","volume-title":"A Transdiagnostic approach to obsessions, compulsions and related phenomena","author":"C Raposo-Lima","year":"2019","unstructured":"Raposo-Lima C, Morgado P. The role of environmental factors in the pathogenesis of obsessive-compulsive and related disorders. In: Fontenelle LF, Y\u00fccel M, editors. A Transdiagnostic approach to obsessions, compulsions and related phenomena. Cambridge: Cambridge University Press; 2019. p. 39\u201350. https:\/\/doi.org\/10.1017\/9781108164313.006."},{"issue":"2","key":"3289_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264\u201371. https:\/\/doi.org\/10.1176\/ajp.155.2.264.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3289_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/fnl.16.4","volume":"11","author":"T Cutforth","year":"2016","unstructured":"Cutforth T, DeMille MM, Agalliu I, Agalliu D. CNS autoimmune disease after streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors. Future Neurol. 2016;11(1):63\u201376. https:\/\/doi.org\/10.2217\/fnl.16.4.","journal-title":"Future Neurol"},{"issue":"1","key":"3289_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1192\/bjp.bp.113.137018","volume":"205","author":"DM Pearlman","year":"2014","unstructured":"Pearlman DM, Vora HS, Marquis BG, Najjar S, Dudley LA. Anti-basal ganglia antibodies in primary obsessive\u2013compulsive disorder: systematic review and meta-analysis. Br J Psychiatry. 2014;205(1):8\u201316. https:\/\/doi.org\/10.1192\/bjp.bp.113.137018.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3289_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.wco.0000073938.19076.31","volume":"16","author":"LA Snider","year":"2003","unstructured":"Snider LA, Swedo SE. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol. 2003;16(3):359\u201365. https:\/\/doi.org\/10.1097\/01.wco.0000073938.19076.31.","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"3289_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-019-1062-8","volume":"21","author":"M Gerentes","year":"2019","unstructured":"Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: autoimmunity and Neuroinflammation. Curr Psychiatry Rep. 2019;21(8):78. https:\/\/doi.org\/10.1007\/s11920-019-1062-8.","journal-title":"Curr Psychiatry Rep"},{"key":"3289_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbi.2019.02.027","volume":"86","author":"S Mora","year":"2020","unstructured":"Mora S, Mart\u00edn-Gonz\u00e1lez E, Flores P, Moreno M. Neuropsychiatric consequences of childhood group a streptococcal infection: a systematic review of preclinical models. Brain Behav Immun. 2020;86:53\u201362. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.027.","journal-title":"Brain Behav Immun"},{"key":"3289_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3389\/fneur.2020.567407","volume":"11","author":"D Martino","year":"2020","unstructured":"Martino D, Johnson I, Leckman JF. What does immunology have to do with Normal brain development and the pathophysiology underlying Tourette syndrome and related neuropsychiatric disorders? Front Neurol. 2020;11:1101.","journal-title":"Front Neurol"},{"issue":"3","key":"3289_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaac.2013.11.013","volume":"53","author":"RH Mitchell","year":"2014","unstructured":"Mitchell RH, Goldstein BI. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry. 2014;53(3):274\u201396. https:\/\/doi.org\/10.1016\/j.jaac.2013.11.013.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"3289_CR11","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","volume":"229","author":"NP Rao","year":"2015","unstructured":"Rao NP, Venkatasubramanian G, Ravi V, Kalmady S, Cherian A, YC JR. Plasma cytokine abnormalities in drug-na\u00efve, comorbidity-free obsessive\u2013compulsive disorder. Psychiatry Res. 2015;229(3):949\u201352. https:\/\/doi.org\/10.1016\/j.psychres.2015.07.009.","journal-title":"Psychiatry Res"},{"issue":"1","key":"3289_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","volume":"14","author":"N Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez N, Morer A, Gonz\u00e1lez-Navarro EA, Serra-Pages C, Boloc D, Torres T, et al. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation. 2017;14(1):261. https:\/\/doi.org\/10.1186\/s12974-017-1042-z.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3289_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","volume":"74","author":"S Attwells","year":"2017","unstructured":"Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, et al. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry. 2017;74(8):833\u201340. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.1567.","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"3289_CR14","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1007\/s12035-018-1409-x","volume":"56","author":"TD Cosco","year":"2019","unstructured":"Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Prina AM, et al. Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol. 2019;56(7):4751\u20139. https:\/\/doi.org\/10.1007\/s12035-018-1409-x.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"3289_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/da.22790","volume":"35","author":"ME Renna","year":"2018","unstructured":"Renna ME, O'Toole MS, Spaeth PE, Lekander M, Mennin DS. The association between anxiety, traumatic stress, and obsessive\u2013compulsive disorders and chronic inflammation: a systematic review and meta-analysis. Depress Anxiety. 2018;35(11):1081\u201394. https:\/\/doi.org\/10.1002\/da.22790.","journal-title":"Depress Anxiety"},{"issue":"6","key":"3289_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.mp.4001645","volume":"10","author":"D Dietrich","year":"2005","unstructured":"Dietrich D, Zhang Y, Bode L, M\u00fcnte T, Hauser U, Schmorl P, et al. Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive\u2013compulsive disorder. Mol Psychiatry. 2005;10(6):519\u201320. https:\/\/doi.org\/10.1038\/sj.mp.4001645.","journal-title":"Mol Psychiatry"},{"issue":"38","key":"3289_CR17","doi-asserted-by":"publisher","first-page":"22565","DOI":"10.1074\/jbc.270.38.22565","volume":"270","author":"Q Liu","year":"1995","unstructured":"Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem. 1995;270(38):22565\u201370. https:\/\/doi.org\/10.1074\/jbc.270.38.22565.","journal-title":"J Biol Chem"},{"issue":"8","key":"3289_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nchembio.402","volume":"6","author":"G Bao","year":"2010","unstructured":"Bao G, Clifton M, Hoette TM, Mori K, Deng S-X, Qiu A, et al. Iron traffics in circulation bound to a siderocalin (Ngal)\u2013catechol complex. Nat Chem Biol. 2010;6(8):602\u20139. https:\/\/doi.org\/10.1038\/nchembio.402.","journal-title":"Nat Chem Biol"},{"key":"3289_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.06.005","volume":"131","author":"AC Ferreira","year":"2015","unstructured":"Ferreira AC, Da Mesquita S, Sousa JC, Correia-Neves M, Sousa N, Palha JA, et al. From the periphery to the brain: Lipocalin-2, a friend or foe? Prog Neurobiol. 2015;131:120\u201336. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.06.005.","journal-title":"Prog Neurobiol"},{"key":"3289_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fncel.2012.00033","volume":"6","author":"F Marques","year":"2012","unstructured":"Marques F, Mesquita SD, Sousa JC, Coppola G, Gao F, Geschwind DH, et al. Lipocalin 2 is present in the EAE brain and is modulated by natalizumab. Front Cell Neurosci. 2012;6:33.","journal-title":"Front Cell Neurosci"},{"key":"3289_CR21","doi-asserted-by":"publisher","first-page":"109779","DOI":"10.1016\/j.jpsychores.2019.109779","volume":"125","author":"PM Mommersteeg","year":"2019","unstructured":"Mommersteeg PM, Naud\u00e9 PJ, Bagijn W, Widdershoven J, Westerhuis BW, Schoemaker RG. Gender differences in associations of depressive symptoms and anxiety with inflammatory markers in patients with non-obstructive coronary artery disease. J Psychosom Res. 2019;125:109779. https:\/\/doi.org\/10.1016\/j.jpsychores.2019.109779.","journal-title":"J Psychosom Res"},{"issue":"5","key":"3289_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jpsychores.2013.08.023","volume":"75","author":"P Naud\u00e9","year":"2013","unstructured":"Naud\u00e9 P, Eisel U, Comijs H, Groenewold N, De Deyn P, Bosker F, et al. Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression. J Psychosom Res. 2013;75(5):444\u201350. https:\/\/doi.org\/10.1016\/j.jpsychores.2013.08.023.","journal-title":"J Psychosom Res"},{"key":"3289_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2013.12.023","volume":"38","author":"PJ Naud\u00e9","year":"2014","unstructured":"Naud\u00e9 PJ, Mommersteeg PM, Zijlstra WP, Gouweleeuw L, Kupper N, Eisel UL, et al. Neutrophil gelatinase-associated lipocalin and depression in patients with chronic heart failure. Brain Behav Immun. 2014;38:59\u201365. https:\/\/doi.org\/10.1016\/j.bbi.2013.12.023.","journal-title":"Brain Behav Immun"},{"key":"3289_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jad.2018.02.080","volume":"234","author":"E Veltman","year":"2018","unstructured":"Veltman E, Lamers F, Comijs H, Stek M, Van der Mast R, Rhebergen D. Inflammatory markers and cortisol parameters across depressive subtypes in an older cohort. J Affect Disord. 2018;234:54\u20138. https:\/\/doi.org\/10.1016\/j.jad.2018.02.080.","journal-title":"J Affect Disord"},{"issue":"3","key":"3289_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/sj.jcbfm.9600557","volume":"28","author":"F Marques","year":"2008","unstructured":"Marques F, Rodrigues A-J, Sousa JC, Coppola G, Geschwind DH, Sousa N, et al. Lipocalin 2 is a choroid plexus acute-phase protein. J Cereb Blood Flow Metab. 2008;28(3):450\u20135. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600557.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"3289_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.WCB.0000123141.67811.91","volume":"24","author":"JP MacManus","year":"2004","unstructured":"MacManus JP, Graber T, Luebbert C, Preston E, Rasquinha I, Smith B, et al. Translation-state analysis of gene expression in mouse brain after focal ischemia. J Cereb Blood Flow Metab. 2004;24(6):657\u201367. https:\/\/doi.org\/10.1097\/01.WCB.0000123141.67811.91.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"3289_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1152\/physiolgenomics.00081.2005","volume":"22","author":"A De Biase","year":"2005","unstructured":"De Biase A, Knoblach SM, Di Giovanni S, Fan C, Molon A, Hoffman EP, et al. Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol Genomics. 2005;22(3):368\u201381. https:\/\/doi.org\/10.1152\/physiolgenomics.00081.2005.","journal-title":"Physiol Genomics"},{"issue":"1","key":"3289_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1523\/JNEUROSCI.2389-11.2012","volume":"32","author":"K-W Poh","year":"2012","unstructured":"Poh K-W, Yeo J-F, Stohler CS, Ong W-Y. Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. J Neurosci. 2012;32(1):35\u201345. https:\/\/doi.org\/10.1523\/JNEUROSCI.2389-11.2012.","journal-title":"J Neurosci"},{"issue":"10","key":"3289_CR29","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/cdd.2014.68","volume":"21","author":"S Mesquita","year":"2014","unstructured":"Mesquita S, Ferreira A, Falcao A, Sousa J, Oliveira TG, Correia-Neves M, et al. Lipocalin 2 modulates the cellular response to amyloid beta. Cell Death Differ. 2014;21(10):1588\u201399. https:\/\/doi.org\/10.1038\/cdd.2014.68.","journal-title":"Cell Death Differ"},{"issue":"7","key":"3289_CR30","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1096\/fj.11-202457","volume":"26","author":"PJ Naud\u00e9","year":"2012","unstructured":"Naud\u00e9 PJ, Nyakas C, Eiden LE, Ait-Ali D, Van Der Heide R, Engelborghs S, et al. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 2012;26(7):2811\u201323. https:\/\/doi.org\/10.1096\/fj.11-202457.","journal-title":"FASEB J"},{"issue":"20","key":"3289_CR31","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1523\/JNEUROSCI.4261-15.2016","volume":"36","author":"B-W Kim","year":"2016","unstructured":"Kim B-W, Jeong KH, Kim J-H, Jin M, Kim J-H, Lee M-G, et al. Pathogenic upregulation of glial lipocalin-2 in the parkinsonian dopaminergic system. J Neurosci. 2016;36(20):5608\u201322. https:\/\/doi.org\/10.1523\/JNEUROSCI.4261-15.2016.","journal-title":"J Neurosci"},{"key":"3289_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fncel.2013.00122","volume":"7","author":"AC Ferreira","year":"2013","unstructured":"Ferreira AC, Pinto V, Mesquita SD, Novais A, Sousa JC, Correia-Neves M, et al. Lipocalin-2 is involved in emotional behaviors and cognitive function. Front Cell Neurosci. 2013;7:122.","journal-title":"Front Cell Neurosci"},{"issue":"45","key":"3289_CR33","doi-asserted-by":"publisher","first-page":"18436","DOI":"10.1073\/pnas.1107936108","volume":"108","author":"M Mucha","year":"2011","unstructured":"Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R. Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc Natl Acad Sci U S A. 2011;108(45):18436\u201341. https:\/\/doi.org\/10.1073\/pnas.1107936108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3289_CR34","doi-asserted-by":"crossref","unstructured":"Skrzypiec AE, Shah RS, Schiavon E, Baker E, Skene N, Pawlak R, et al. Stress-induced lipocalin-2 controls dendritic spine formation and neuronal activity in the amygdala. PLoS One. 2013;8(4):e61046.","DOI":"10.1371\/journal.pone.0061046"},{"issue":"4","key":"3289_CR35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mp.2017.95","volume":"23","author":"A Ferreira","year":"2018","unstructured":"Ferreira A, Santos T, Sampaio-Marques B, Novais A, Mesquita S, Ludovico P, et al. Lipocalin-2 regulates adult neurogenesis and contextual discriminative behaviours. Mol Psychiatry. 2018;23(4):1031\u20139. https:\/\/doi.org\/10.1038\/mp.2017.95.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3289_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00213-010-2085-3","volume":"214","author":"A-J Rodrigues","year":"2011","unstructured":"Rodrigues A-J, Le\u00e3o P, Carvalho M, Almeida OF, Sousa N. Potential programming of dopaminergic circuits by early life stress. Psychopharmacology. 2011;214(1):107\u201320. https:\/\/doi.org\/10.1007\/s00213-010-2085-3.","journal-title":"Psychopharmacology."},{"key":"3289_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fpsyt.2018.00431","volume":"9","author":"P Castro-Rodrigues","year":"2018","unstructured":"Castro-Rodrigues P, Camacho M, Almeida S, Marinho M, Soares C, Barahona-Corr\u00eaa JB, et al. Criterion validity of the Yale-Brown obsessive-compulsive scale second edition for diagnosis of obsessive-compulsive disorder in adults. Front Psychiatry. 2018;9:431. https:\/\/doi.org\/10.3389\/fpsyt.2018.00431.","journal-title":"Front Psychiatry"},{"issue":"11","key":"3289_CR38","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive compulsive scale: I. development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006\u201311. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007.","journal-title":"Arch Gen Psychiatry"},{"key":"3289_CR39","volume-title":"SPSS statistics for Macintosh, version 27.0","author":"I Corp","year":"2020","unstructured":"Corp I. SPSS statistics for Macintosh, version 27.0. IBM Corp: Armonk, NY; 2020."},{"issue":"7","key":"3289_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/15622975.2015.1062550","volume":"16","author":"PJ Naud\u00e9","year":"2015","unstructured":"Naud\u00e9 PJ, Mommersteeg PM, Gouweleeuw L, Eisel UL, Denollet J, Westerhuis LW, et al. NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure. World J Biol Psychiatry. 2015;16(7):536\u201341. https:\/\/doi.org\/10.3109\/15622975.2015.1062550.","journal-title":"World J Biol Psychiatry"},{"key":"3289_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2014.12.026","volume":"46","author":"L Gouweleeuw","year":"2015","unstructured":"Gouweleeuw L, Naud\u00e9 P, Rots M, DeJongste M, Eisel U, Schoemaker R. The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease. Brain Behav Immun. 2015;46:23\u201332. https:\/\/doi.org\/10.1016\/j.bbi.2014.12.026.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"3289_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0889-1591(02)00004-1","volume":"16","author":"T Pollm\u00e4cher","year":"2002","unstructured":"Pollm\u00e4cher T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines\u2014do they affect human brain functions? Brain Behav Immun. 2002;16(5):525\u201332. https:\/\/doi.org\/10.1016\/S0889-1591(02)00004-1.","journal-title":"Brain Behav Immun"},{"key":"3289_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jad.2017.10.002","volume":"226","author":"L Wei","year":"2018","unstructured":"Wei L, Du Y, Wu W, Fu X, Xia Q. Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients. J Affect Disord. 2018;226:307\u201312. https:\/\/doi.org\/10.1016\/j.jad.2017.10.002.","journal-title":"J Affect Disord"},{"issue":"2","key":"3289_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/mp.2016.243","volume":"23","author":"SS Kang","year":"2018","unstructured":"Kang SS, Ren Y, Liu C-C, Kurti A, Baker KE, Bu G, et al. Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry. 2018;23(2):344\u201350. https:\/\/doi.org\/10.1038\/mp.2016.243.","journal-title":"Mol Psychiatry"},{"key":"3289_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","volume":"96","author":"EV Mike","year":"2019","unstructured":"Mike EV, Makinde HM, Gulinello M, Vanarsa K, Herlitz L, Gadhvi G, et al. Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus. J Autoimmun. 2019;96:59\u201373. https:\/\/doi.org\/10.1016\/j.jaut.2018.08.005.","journal-title":"J Autoimmun"},{"issue":"10","key":"3289_CR46","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00213-019-05190-7","volume":"236","author":"EG Vichaya","year":"2019","unstructured":"Vichaya EG, Gross PS, Estrada DJ, Cole SW, Grossberg AJ, Evans SE, et al. Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior. Psychopharmacology. 2019;236(10):2975\u201382. https:\/\/doi.org\/10.1007\/s00213-019-05190-7.","journal-title":"Psychopharmacology."},{"key":"3289_CR47","doi-asserted-by":"crossref","unstructured":"Bhusal A, Rahman MH, Lee W-H, Bae YC, Lee I-K, Suk K. Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications. Biochem Pharmacol. 2019;113626.","DOI":"10.1016\/j.bcp.2019.113626"},{"issue":"10","key":"3289_CR48","doi-asserted-by":"publisher","first-page":"e12779","DOI":"10.1111\/jne.12779","volume":"31","author":"K Pinyopornpanish","year":"2019","unstructured":"Pinyopornpanish K, Chattipakorn N, Chattipakorn SC. Lipocalin-2: its perspectives in brain pathology and possible roles in cognition. J Neuroendocrinol. 2019;31(10):e12779. https:\/\/doi.org\/10.1111\/jne.12779.","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"3289_CR49","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/npp.2009.77","volume":"34","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar S. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive\u2013compulsive disorder. Neuropsychopharmacology. 2009;34(12):2489\u201396. https:\/\/doi.org\/10.1038\/npp.2009.77.","journal-title":"Neuropsychopharmacology."},{"issue":"2","key":"3289_CR50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3233\/JAD-160330","volume":"55","author":"DW Dekens","year":"2017","unstructured":"Dekens DW, Naud\u00e9 PJ, Engelborghs S, Vermeiren Y, Van Dam D, Oude Voshaar RC, et al. Neutrophil gelatinase-associated lipocalin and its receptors in Alzheimer\u2019s disease (AD) brain regions: differential findings in AD with and without depression. J Alzheimers Dis. 2017;55(2):763\u201376. https:\/\/doi.org\/10.3233\/JAD-160330.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"3289_CR51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuroscience.2009.10.043","volume":"165","author":"J Rotge","year":"2010","unstructured":"Rotge J, Aouizerate B, Tignol J, Bioulac B, Burbaud P, Guehl D. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience. 2010;165(2):408\u201317. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.10.043.","journal-title":"Neuroscience."},{"issue":"4","key":"3289_CR52","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","volume":"100","author":"K Wu","year":"2012","unstructured":"Wu K, Hanna GL, Rosenberg DR, Arnold PD. The role of glutamate signaling in the pathogenesis and treatment of obsessive\u2013compulsive disorder. Pharmacol Biochem Behav. 2012;100(4):726\u201335. https:\/\/doi.org\/10.1016\/j.pbb.2011.10.007.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03289-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T04:03:27Z","timestamp":1622001807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03289-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by Ethics Subcommittee for the Life and Health Sciences of University of Minho, Portugal, and by the Ethics Committee of the Hospital of Braga, Portugal. All subjects were provided with written informed consent following description of the study goals and procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P Morgado has received in the past 3\u2009years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial Foundation, Biogen, DGS-Portugal, FCT, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede and 2CA-Braga. C Raposo-Lima, IM Pereira and F Marques declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}